Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
Broadening the MIND: Tafasitamab and Lenalidomide versus Synthetic ControlsHua-Jay J Cherng, Jason R WestinLeukemia & Lymphoma|May 13, 2022
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphomaMax J Gordon, Anna Sureda, Jason R WestinBritish Journal of Haematology|December 23, 2014
A clinician's guide to double hit lymphomasChan Yoon Cheah, Yasuhiro Oki, Jason R Westin, et al.Case Reports in Medicine|July 20, 2012
Hodgkin lymphoma untreated for six years presenting with tracheoesophageal fistulaJason R Westin, Amye Gibbs, Keith R Mills, et al.Clinical Imaging|March 2, 2015
Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature reviewPauline L Bui, Rafael A Vicens, Jason R Westin, et al.Current Opinion in Hematology|June 4, 2002
Molecular diagnosis of lymphoid malignancies by gene expression profilingR Eric Davis, Louis M StaudtJournal of Clinical Pharmacy and Therapeutics|May 22, 2019
A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patientAlan L Myers, Jitesh D Kawedia, Ahmed Nader, et al.Clinical Lymphoma, Myeloma & Leukemia|August 26, 2019
Rosai-Dorfman Disease: The MD Anderson Cancer Center ExperienceVishwanath Sathyanarayanan, Amir Issa, Raisa Pinto, et al.Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.Blood|June 25, 2017
Tonic B-cell receptor signaling in diffuse large B-cell lymphomaOndrej Havranek, Jingda Xu, Stefan Köhrer, et al.Pageof 18